ArticleEMBO molecular medicine2024

Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells.

Jan Mueller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.